1. 1. Saseen J, Nappi J. Dyslipidemia, atherosclerosis, and coronary heart disease. In: Alldredge B, Corelli R, Ernst M, Guglielmo BJ, Jacobson P et al. Koda-kimble & young's applied therapeutics the clinical use of drugs (10th ed). Philadelphia; Lippincott William & Wilkins; 2013; 252-290.
2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020
3. Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolemia;Climent;Nutr Metab Cardiovasc Dis,2021
4. 4. Kon YC. High-density lipoprotein cholesterol: ready for prime time? Singapore Med J. 2005;46:507-513.
5. Combination of simvastatin with berberine improves the lipid-lowering efficacy;Kong;Metabolism,2008